Fostering Global Networking
for Better Prevention and Care of Atherosclerosis
THE LATEST
THE LATEST
- Apply Today: 5th Wael Almahmeed & IAS Research Training Fellowships: Middle East and Africa
- Joint CEDA/IAS Session at CEDA 2023
- Joint SOCESP/IAS Symposium: Insights on Residual Risk
- The IAS released a new video series, Obesity Management: The Window of Opportunity for Cardiometabolic Clinicians, in the IAS Education Center
- Iraqi Lipid Clinics Network president Dr. Mutaz Al-Khnifsawi’s Lipid Spin guest editorial Fighting the Impossible
- Winners Announced: 4th Wael Almahmeed & IAS Research Training Fellowships: Middle East and Africa
President’s Message
Prof. Peter Libby
President of the International Atherosclerosis Society
Among IAS’ goals is collaboration with other societies and stakeholders to foster research and education on cardio-cerebro-metabolic and thrombosis risk factors. To this end, IAS is engaged as a global scientific partner of INTERASPIRE. INTERASPIRE is an international study of more than 4,000 coronary patients across 14 countries. It aims to:
- Describe prevalence of cardiometabolic and renal risk factors
- Describe current risk factor management to defined targets by drug therapies
- Provide an objective assessment of clinical implementation of international and national cardiovascular guidelines
- Investigate the reasons for variation in preventive cardiology practice between regions and countries
- Promote the principles of best preventive cardiology practice through continental and national societies of cardiology and heart foundations.
Newsletter
Monthly e-Newsletter
The IAS e-Newsletter is a monthly digest of the latest from the IAS and our Constituent Member Societies.
Weekly and Monthly Statin e-Newsletter
Going well beyond “Statins,” this resource is a clinical tool on the latest information confronting clinicians and researchers.
Monthly Lipid Lowering Drugs e-Newsletter
This members-only newsletter provides an update on new lipid lowering drugs.